Abstract

Chater I Introduction
	1.1 Introduction to chronic hepatities B
		1.1.1 The prevalence of Hepatities B
		1.1.2 Route of transmission
		1.1.3 Symptoms
	1.2 Introduction to hepatities B virus
		1.2.1 HBV and Hepadnaviridae
		1.2.2 Genome structure of HBV
		1.2.3 Duplication mechanism
	1.3 Drug-resistance study
		1.3.1 Anti_HBV drugs
		1.3.2 Reasons of drug-resistance
		1.3.3 Clinical classification of resistance
		1.3.4 Treatments selections
		1.3.5 Prevention of drug-resistance
Chater II Techniques development of HBV quasispecies study
	2.1 HBV quasispecies study methods
	2.2 Sequencing technology development
	2.3 Application of UDPS in quasispecies study

Chater III Raw data collection and process
	3.1 Materials and methods
		3.1.1 Sequencing material source
		3.1.2 Softwares
		3.1.3 Methods
	3.2 Results
		3.2.1 System error rate of sequencing
		3.2.2 Reads statistics 
		3.2.3 Reads repair and filter
		3.2.4 Validated reads
		3.2.5 Genotyping
		3.2.6 Clinical classification of patients
	3.3 Discussion

Chater IV Baseline analysis
	4.1 Materials and methods
		4.1.1 Materials
		4.1.2 Softwares
		4.1.3 Methods
	4.2 Results
		4.2.1 RT mutation rates of all patients in baseline
		4.2.2 Known drug-resistant mutation screen
		4.2.3 Conservative and variable regions
		4.2.4 Immunologic escape screen in S
	4.3 Discussion

Chater V Sequential analysis
	5.1 Materials and methods
		5.1.1 Materials
		5.1.2 Softwares
		5.1.3 Methods
	5.2 Results
		5.2.1 RT mutation rates of partial responders and viral rebound patients during treatment
		5.2.2 Known LdT resistant mutations screen and dynamics
		5.2.3 Comman mutations related with treatment and refinement
		5.2.4 Ligand-docking analysis
	5.3 Discussion

Chater VI Conclusions
	
	

	
